Ameriprise Financial Inc Fibrogen Inc Transaction History

Ameriprise Financial Inc

  • $381 Billion
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$0.89 - $2.36 $149,695 - $396,944
-168,197 Reduced 81.88%
37,227 $33,000
Q1 2024

May 15, 2024
SELL
$0.73 - $2.73 $57,580 - $215,336
-78,878 Reduced 27.74%
205,424 $482,000
Q4 2023

Feb 14, 2024
SELL
$0.38 - $0.91 $9 - $22
-25 Reduced 0.01%
284,302 $253,000
Q3 2023

Nov 14, 2023
BUY
$0.79 - $2.83 $205,802 - $737,243
260,510 Added 1093.8%
284,327 $244,000
Q2 2023

Aug 14, 2023
SELL
$2.49 - $20.59 $2,201 - $18,201
-884 Reduced 3.58%
23,817 $64,000
Q1 2023

May 15, 2023
SELL
$15.95 - $25.18 $48,567 - $76,673
-3,045 Reduced 10.97%
24,701 $460,000
Q4 2022

Feb 14, 2023
BUY
$13.27 - $17.73 $1,061 - $1,418
80 Added 0.29%
27,746 $444,000
Q3 2022

Nov 14, 2022
BUY
$11.4 - $14.6 $315,392 - $403,923
27,666 New
27,666 $360,000
Q4 2021

Feb 14, 2022
SELL
$9.93 - $15.39 $292,220 - $452,896
-29,428 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$10.18 - $26.64 $195,578 - $511,807
-19,212 Reduced 39.5%
29,428 $301,000
Q2 2021

Aug 16, 2021
SELL
$18.57 - $35.68 $366,330 - $703,859
-19,727 Reduced 28.85%
48,640 $1.3 Million
Q1 2021

May 17, 2021
SELL
$31.0 - $55.72 $162,781 - $292,585
-5,251 Reduced 7.13%
68,367 $2.37 Million
Q4 2020

Feb 12, 2021
SELL
$37.09 - $48.97 $50,924 - $67,235
-1,373 Reduced 1.83%
73,618 $2.73 Million
Q3 2020

Nov 16, 2020
SELL
$40.47 - $45.5 $673,704 - $757,438
-16,647 Reduced 18.17%
74,991 $3.08 Million
Q2 2020

Aug 14, 2020
SELL
$32.57 - $42.83 $755,917 - $994,041
-23,209 Reduced 20.21%
91,638 $3.71 Million
Q1 2020

May 15, 2020
BUY
$23.3 - $45.96 $213,078 - $420,304
9,145 Added 8.65%
114,847 $3.99 Million
Q4 2019

Feb 14, 2020
BUY
$34.58 - $48.06 $110,794 - $153,984
3,204 Added 3.13%
105,702 $4.53 Million
Q3 2019

Nov 14, 2019
SELL
$36.98 - $48.45 $296,616 - $388,617
-8,021 Reduced 7.26%
102,498 $3.79 Million
Q2 2019

Aug 14, 2019
SELL
$35.13 - $55.53 $1.62 Million - $2.56 Million
-46,132 Reduced 29.45%
110,519 $4.99 Million
Q1 2019

May 15, 2019
BUY
$42.83 - $59.91 $5.16 Million - $7.22 Million
120,503 Added 333.36%
156,651 $8.51 Million
Q4 2018

Feb 14, 2019
SELL
$37.97 - $60.16 $793,610 - $1.26 Million
-20,901 Reduced 36.64%
36,148 $1.67 Million
Q3 2018

Nov 14, 2018
BUY
$56.3 - $67.25 $284,483 - $339,814
5,053 Added 9.72%
57,049 $3.47 Million
Q2 2018

Aug 14, 2018
BUY
$44.9 - $64.95 $1.16 Million - $1.68 Million
25,804 Added 98.52%
51,996 $3.26 Million
Q1 2018

May 15, 2018
SELL
$45.35 - $61.65 $12,924 - $17,570
-285 Reduced 1.08%
26,192 $1.21 Million
Q4 2017

Feb 12, 2018
SELL
$41.95 - $60.1 $290,042 - $415,531
-6,914 Reduced 20.71%
26,477 $1.26 Million
Q3 2017

Nov 07, 2017
BUY
$33.4 - $53.9 $1.12 Million - $1.8 Million
33,391
33,391 $1.8 Million

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email